BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2702103)

  • 1. In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy.
    Lin CY; Chen CH; Lee PP
    Pediatr Nephrol; 1989 Jul; 3(3):254-8. PubMed ID: 2702103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy.
    Chen WP; Lin CY
    Nephron; 1994; 68(1):10-9. PubMed ID: 7991018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced suppressor T cell activity resulting in increased IgM and decreased IgG productions in children with minimal change nephrotic syndrome.
    Chen CH; Hsieh KH; Lee PP
    Int J Pediatr Nephrol; 1987; 8(2):75-80. PubMed ID: 2958423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome].
    Maruyama M; Toyoda M; Umezono T; Miyauchi M; Yamamoto N; Kimura M; Honma M; Nishina M; Endoh M; Sakai H; Suzuki D
    Nihon Jinzo Gakkai Shi; 2006; 48(1):14-21. PubMed ID: 16480062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.
    Herrod HG; Stapleton FB; Trouy RL; Roy S
    Clin Exp Immunol; 1983 Jun; 52(3):581-5. PubMed ID: 6603300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of mesangial IgM deposits and mesangial hypercellularity in minimal change nephrotic syndrome.
    Pardo V; Riesgo I; Zilleruelo G; Strauss J
    Am J Kidney Dis; 1984 Jan; 3(4):264-9. PubMed ID: 6691342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children.
    Zeis PM; Kavazarakis E; Nakopoulou L; Moustaki M; Messaritaki A; Zeis MP; Nicolaidou P
    Pediatr Int; 2001 Jun; 43(3):287-92. PubMed ID: 11380926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin synthesis by peripheral blood mononuclear cells in minimal change nephrotic syndrome.
    Beale MG; Nash GS; Bertovich MJ; MacDermott RP
    Kidney Int; 1983 Feb; 23(2):380-6. PubMed ID: 6601737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B lymphocyte subset patterns and their significance in idiopathic glomerulonephritis.
    Tani Y; Kida H; Abe T; Tomosugi N; Saito Y; Asamoto T; Hattori N
    Clin Exp Immunol; 1982 Apr; 48(1):201-4. PubMed ID: 6979448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis.
    Rothschild E; Chatenoud L
    Kidney Int; 1984 Mar; 25(3):557-64. PubMed ID: 6234421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM nephropathy in children: clinicopathologic analysis.
    Arias LF; Prada MC; VĂ©lez-Echeverri C; Serna-Higuita LM; Serrano-Gayubo AK; Ochoa CL; Vanegas-Ruiz JJ
    Nefrologia; 2013; 33(4):532-8. PubMed ID: 23897185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood IgM nephropathy: comparison with minimal change disease.
    Al-Eisa A; Carter JE; Lirenman DS; Magil AB
    Nephron; 1996; 72(1):37-43. PubMed ID: 8903859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and long-term evolution of minimal change histopathologic variants and of IGM nephropathy among Egyptians.
    Donia AF; Sobh MA; Moustafa FE; Bakr MA; Foda MA
    J Nephrol; 2000; 13(4):275-81. PubMed ID: 10946807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired immunoglobulin G production in minimal change nephrotic syndrome in adults.
    Yokoyama H; Kida H; Abe T; Koshino Y; Yoshimura M; Hattori N
    Clin Exp Immunol; 1987 Oct; 70(1):110-5. PubMed ID: 3500811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of circulating immune complexes and lymphocyte subpopulations in childhood IgM mesangial nephropathy.
    Lin CY; Chu CM
    Nephron; 1986; 44(3):198-203. PubMed ID: 3491333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesangial IGM in minimal change glomerular disease: a clinicopathological study in a Malaysian population.
    Looi LM; Wang F; Lam KL; Chua CT
    Pathology; 1985 Jan; 17(1):41-4. PubMed ID: 3889788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
    Choi J; Jeong HJ; Lee HY; Kim PK; Lee JS; Han DS
    Yonsei Med J; 1990 Sep; 31(3):258-63. PubMed ID: 2281685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?
    Vintar Spreitzer M; Vizjak A; Ferluga D; Kenda RB; Kersnik Levart T
    Pediatr Nephrol; 2014 Jan; 29(1):67-74. PubMed ID: 23852271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesangial proliferative glomerulonephritis with IgM deposits. Clinicopathologic analysis and evidence for morphologic transitions.
    Hirszel P; Yamase HT; Carney WR; Galen MA; Graeber CW; Johnson KJ; Kennedy TL; Lapkin RA; McLean RH; Rosenworcel E
    Nephron; 1984; 38(2):100-8. PubMed ID: 6382035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.